Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform (TARGET-RCC)

San Donato Group (GSD)

Status: Not yet enrolling

Conditions: Renal Tumors

Study type: Observational

Funder types: Other

Identifiers

NCT06868927

TARGET-RCC

Details and patient eligibility

About

This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indicative of response to systemic agents or ablative therapy.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Presence of a renal mass up to 4 cm
• Adult > 18 years
• Candidate to renal surgery
• Informed consent signed

Exclusion criteria

• Contraindication for MRI